NIMH Data Archive - Data

Genomics

Neuroimaging

Phenotype¹

New Trial
Clinical Trial

¹ Numbers reported are subjects by age

New Project
Grant/Project Number

Format should be in the following format: Activity Code, Institute Abbreviation, and Serial Number. Grant Type, Support Year, and Suffix should be excluded. For example, grant 1R01MH123456-01A1 should be entered R01MH123456

Collection - Use Existing Experiment

To associate an experiment to the current collection, just select an axperiment from the table below then click the associate experiment button to persist your changes (saving the collection is not required). Note that once an experiment has been associated to two or more collections, the experiment will not longer be editable.

The table search feature is case insensitive and targets the experiment id, experiment name and experiment type columns. The experiment id is searched only when the search term entered is a number, and filtered using a startsWith comparison. When the search term is not numeric the experiment name is used to filter the results.

Select	Experiment Id	Experiment Name	Experiment Type	Created On

24	HI-NGS_R1	Omics	02/16/2011
475	MB1-10 (CHOP)	Omics	06/07/2016
490	Illumina Infinium PsychArray BeadChip Assay	Omics	07/07/2016
501	PharmacoBOLD Resting State	fMRI	07/27/2016
506	PVPREF	Omics	08/05/2016
509	ABC-CT Resting v2	EEG	08/18/2016
13	Comparison of FI expression in Autistic and Neurotypical Homo Sapiens	Omics	12/28/2010
18	AGRE/Broad Affymetrix 5.0 Genotype Experiment	Omics	01/06/2011
22	Stitching PCR Sequencing	Omics	02/14/2011
26	ASD_Methylation	Omics	03/01/2011
29	Microarray family 03 (father, mother, sibling)	Omics	03/24/2011
37	Standard paired-end sequencing of BCRs	Omics	04/19/2011
38	Illumina Mate-Pair BCR sequencing	Omics	04/19/2011
39	Custom Jumping Libraries	Omics	04/19/2011
40	Custom CapBP	Omics	04/19/2011
41	Immunofluorescence	Omics	05/11/2011
43	Autism brain sample genotyping, Illumina	Omics	05/16/2011
47	ARRA Autism Sequencing Collaboration at Baylor. SOLiD 4 System	Omics	08/01/2011
53	AGRE Omni1-quad	Omics	10/11/2011
59	AGP genotyping	Omics	04/03/2012
60	Ultradeep 454 sequencing of synaptic genes from postmortem cerebella of individuals with ASD and neurotypical controls	Omics	06/23/2012
63	Microemulsion PCR and Targeted Resequencing for Variant Detection in ASD	Omics	07/20/2012
76	Whole Genome Sequencing in Autism Families	Omics	01/03/2013
519	Resting	fMRI	11/08/2016
90	Genotyped IAN Samples	Omics	07/09/2013
91	NJLAGS Axiom Genotyping Array	Omics	07/16/2013
93	AGP genotyping (CNV)	Omics	09/06/2013
106	Longitudinal Sleep Study. H20 200. Channel set 2	EEG	11/07/2013
107	Longitudinal Sleep Study. H20 200. Channel set 3	EEG	11/07/2013
108	Longitudinal Sleep Study. AURA 200	EEG	11/07/2013
105	Longitudinal Sleep Study. H20 200. Channel set 1	EEG	11/07/2013
109	Longitudinal Sleep Study. AURA 400	EEG	11/07/2013
116	Gene Expression Analysis WG-6	Omics	01/07/2014
131	Jeste Lab UCLA ACEii: Charlie Brown and Sesame Street - Project 1	Eye Tracking	02/27/2014
132	Jeste Lab UCLA ACEii: Animacy - Project 1	Eye Tracking	02/27/2014
133	Jeste Lab UCLA ACEii: Mom Stranger - Project 2	Eye Tracking	02/27/2014
134	Jeste Lab UCLA ACEii: Face Emotion - Project 3	Eye Tracking	02/27/2014
145	AGRE/FMR1_Illumina.JHU	Omics	04/14/2014
146	AGRE/MECP2_Sanger.JHU	Omics	04/14/2014
147	AGRE/MECP2_Junior.JHU	Omics	04/14/2014
151	Candidate Gene Identification in familial Autism	Omics	06/09/2014
152	NJLAGS Whole Genome Sequencing	Omics	07/01/2014
154	Math Autism Study - Vinod Menon	fMRI	07/15/2014
155	Resting	fMRI	07/25/2014
156	Speech	fMRI	07/25/2014
159	Emotion	fMRI	07/25/2014
160	syllable contrast	EEG	07/29/2014
167	School-age naturalistic stimuli	Eye Tracking	09/19/2014
44	AGRE/Broad Affymetrix 5.0 Genotype Experiment	Omics	06/27/2011
45	Exome Sequencing of 20 Sporadic Cases of Autism Spectrum Disorder	Omics	07/15/2011

Collection - Add Experiment

Add Supporting Documentation

Funding Source:
URL:

To add an existing Data Structure, enter its title in the search bar. If you need to request changes, select the indicator "No, it requires changes to meet research needs" after selecting the Structure, and upload the file with the request changes specific to the selected Data Structure. Your file should follow the Request Changes Procedure. If the Data Structure does not exist, select "Request New Data Structure" and upload the appropriate zip file.

Use/Modify Existing Data Structure

Request New Data Structure

Targeted Enrollment:

Initial Submission Date:

Initial Share Date:

Data Structure Search:

Data Structures:

Submit

Request Submission Exemption

Not Eligible

The Data Expected list for this Collection shows some raw data as missing. Contact the NDA Help Desk with any questions.

Please confirm that you will not be enrolling any more subjects and that all raw data has been collected and submitted.

Collection Updated

Your Collection is now in Data Analysis phase and exempt from biannual submissions. Analyzed data is still expected prior to publication or no later than the project end date.

[CMS] Error

[CMS]

Unable to change collection phase where targeted enrollment is less than 90%

You have requested to move the sharing dates for the following assessments:

Data Expected Item	Original Sharing Date	New Sharing Date

Please provide a reason for this change, which will be sent to the Program Officers listed within this collection:

Explanation must be between 20 and 200 characters in length.

Please press Save or Cancel

Mechanisms of neocortical and sensory hyperexcitability in Fragile X Syndrome #2373

General
Experiments (4)
Shared Data
Publications (63)
Data Expected (14)
Associated Studies (1)

Collection Title	Collection Investigators	Collection Description
Collection Title:	Mechanisms of neocortical and sensory hyperexcitability in Fragile X Syndrome
Collection Investigators:	Kimberly Huber
Collection Description:	Sensory hypersensitivity is commonly seen in FXS patients and the FXS mouse model - the Fmr1 knockout KO. Recent data suggests that this abnormality stems from hyperexcitability in sensory circuits. We have established that cortical microcircuits are hyperexcitable in the Fmr1 KO mouse model, and that sensory responses are enhanced in Fmrl KO mice and FXS patients. Thus, investigation of sensory sensitivities is clinically relevant, but perhaps more important is the promise of sensory system studies to advance understanding of the mechanisms and consequences of hyperexcitabiity in neocortical circuitry that could represent a primary pathophysiological factor impacting the development of a wide range of perceptual, cognitive, and language skills in FXS. Further, we have identified biochemical signaling mechanisms that may underlie hyperexcitability involving processes that we and others have uncovered that can be examined in detail in KO mouse models and tested in FXS patients to develop a foundation for novel therapeutic development. The striking consistency of findings across levels of investigation and species offers an unprecedented opportunity to investigate mechanisms of brain dysfunction in a mouse disease model and translate it directly to patients - a multidisciplinary mission that is ideal for a Center environment. Our Center is organized to pursue precisely this aim with a tightly integrated and highly novel scientific program of translational research. Project 1 HuberGibson UTSW co-PIs will determine the cellular, molecular and synaptic mechanisms of auditory neocortical dysfunction using in vitro brain slices in FXS mouse models. Proecf 2 RazakEtheilBinder UCR co-PIs will study auditory sensory processing deficits in vivo in FXS mouse models, test mechanisms, and examine developmental and structural correlates of these deficits. Prpecf 3 SweeneyByerly, UTSW, co-PIs will investigate auditory cortical processing deficits using novel neurophysiological strategies in individuals with FXS. All Projects will examine candidate mechanisms of sensory hyperexcitability with an acute pharmacological probe strategy to test mechanisms of interest in parallel studies of mice and patients.
Data Repository:	NIMH Data Archive
Permission Group:
Collection Creation Date:	05/04/2016
Collection Phase:	Funding Completed
Collection Sub-Phase:	Close Out
Blinded Clinical Trial:	No
Total Funded Amount:	$5,311,333.00
Subjects Shared:	348

{"values":[]}

Loading Chart...

Funding Sources:

Funding Source Name	Funding Source URL
NIH - Extramural	None

Supporting Documentation:

Grant Information:

Project Number	Project Title	Start Date	End Date	Planned Enrollment	Actual Enrollment	Organization	Funds Obligated
U54HD082008-01	Mechanisms of neocortical and sensory hyperexcitability in Fragile X Syndrome	09/22/2014	05/31/2019	0	279	UT SOUTHWESTERN MEDICAL CENTER	$5,311,333.00

Clinical Trials:

Brief Summary	Status	Clinical Trial ID	Study ID	Principal Investigator	Start Date	End Date
The aim of this study is to utilize neurophysiologic assessments, behavioral measures and clinical measures to assess how much deficits associated with Fragile X Syndrome from pre-dose to post-dose using pharmacology.	Completed	NCT02998151	CIN001 - {LAM}	Craig A Erickson, M.D.	January 2016	November 2020

helpcenter.collection.general-tab

Collection - General Tab

Fields available for edit on the top portion of the page include:

Collection Title
Investigators
Collection Description
Collection Phase
Funding Source
Clinical Trials

Collection Phase: The current status of a research project submitting data to an NDA Collection, based on the timing of the award and/or the data that have been submitted.

Pre-Enrollment: The default entry made when the NDA Collection is created.
Enrolling: Data have been submitted to the NDA Collection or the NDA Data Expected initial submission date has been reached for at least one data structure category in the NDA Collection.
Data Analysis: Subject level data collection for the research project is completed and has been submitted to the NDA Collection. The NDA Collection owner or the NDA Help Desk may set this phase when they’ve confirmed data submission is complete and submitted subject counts match at least 90% of the target enrollment numbers in the NDA Data Expected. Data submission reminders will be turned off for the NDA Collection.
Funding Completed: The NIH grant award (or awards) associated with the NDA Collection has reached its end date. NDA Collections in Funding Completed phase are assigned a subphase to indicate the status of data submission.
- The Data Expected Subphase indicates that NDA expects more data will be submitted
- The Closeout Subphase indicates the data submission is complete.
- The Sharing Not Met Subphase indicates that data submission was not completed as expected.

Blinded Clinical Trial Status:

This status is set by a Collection Owner and indicates the research project is a double blinded clinical trial. When selected, the public view of Data Expected will show the Data Expected items and the Submission Dates, but the targeted enrollment and subjects submitted counts will not be displayed.
Targeted enrollment and subjects submitted counts are visible only to NDA Administrators and to the NDA Collection or as the NDA Collection Owner.
When an NDA Collection that is flagged Blinded Clinical Trial reaches the maximum data sharing date for that Data Repository (see https://nda.nih.gov/nda/sharing-regimen.html), the embargo on Data Expected information is released.

Funding Source

The organization(s) responsible for providing the funding is listed here.

Supporting Documentation

Users with Submission privileges, as well as Collection Owners, Program Officers, and those with Administrator privileges, may upload and attach supporting documentation. By default, supporting documentation is shared to the general public, however, the option is also available to limit this information to qualified researchers only.

Grant Information

Identifiable details are displayed about the Project of which the Collection was derived from. You may click in the Project Number to view a full report of the Project captured by the NIH.

Clinical Trials

Any data that is collected to support or further the research of clinical studies will be available here. Collection Owners and those with Administrator privileges may add new clinical trials.

Frequently Asked Questions

How does the NIMH Data Archive (NDA) determine which Permission Group data are submitted into?

During Collection creation, NDA staff determine the appropriate Permission Group based on the type of data to be submitted, the type of access that will be available to data access users, and the information provided by the Program Officer during grant award.
How do I know when a NDA Collection has been created?

When a Collection is created by NDA staff, an email notification will automatically be sent to the PI(s) of the grant(s) associated with the Collection to notify them.
Is a single grant number ever associated with more than one Collection?

The NDA system does not allow for a single grant to be associated with more than one Collection; therefore, a single grant will not be listed in the Grant Information section of a Collection for more than one Collection.
Why is there sometimes more than one grant included in a Collection?

In general, each Collection is associated with only one grant; however, multiple grants may be associated if the grant has multiple competing segments for the same grant number or if multiple different grants are all working on the same project and it makes sense to hold the data in one Collection (e.g., Cooperative Agreements).

Glossary

Administrator Privilege

A privilege provided to a user associated with an NDA Collection or NDA Study whereby that user can perform a full range of actions including providing privileges to other users.
Collection Owner

Generally, the Collection Owner is the contact PI listed on a grant. Only one NDA user is listed as the Collection owner. Most automated emails are primarily sent to the Collection Owner.
Collection Phase
The Collection Phase provides information on data submission as opposed to grant/project completion so while the Collection phase and grant/project phase may be closely related they are often different. Collection users with Administrative Privileges are encouraged to edit the Collection Phase. The Program Officer as listed in eRA (for NIH funded grants) may also edit this field. Changes must be saved by clicking the Save button at the bottom of the page. This field is sortable alphabetically in ascending or descending order. Collection Phase options include:
- Pre-Enrollment: A grant/project has started, but has not yet enrolled subjects.
- Enrolling: A grant/project has begun enrolling subjects. Data submission is likely ongoing at this point.
- Data Analysis: A grant/project has completed enrolling subjects and has completed all data submissions.
- Funding Completed: A grant/project has reached the project end date.
Collection Title

An editable field with the title of the Collection, which is often the title of the grant associated with the Collection.
Grant

Provides the grant number(s) for the grant(s) associated with the Collection. The field is a hyperlink so clicking on the Grant number will direct the user to the grant information in the NIH Research Portfolio Online Reporting Tools (RePORT) page.
Supporting Documentation

Various documents and materials to enable efficient use of the data by investigators unfamiliar with the project and may include the research protocol, questionnaires, and study manuals.
NIH Research Initiative

NDA Collections may be organized by scientific similarity into NIH Research Initiatives, to facilitate query tool user experience. NIH Research Initiatives map to one or multiple Funding Opportunity Announcements.
Permission Group

Access to shared record-level data in NDA is provisioned at the level of a Permission Group. NDA Permission Groups consist of one or multiple NDA Collections that contain data with the same subject consents.
Planned Enrollment

Number of human subject participants to be enrolled in an NIH-funded clinical research study. The data is provided in competing applications and annual progress reports.
Actual Enrollment

Number of human subjects enrolled in an NIH-funded clinical research study. The data is provided in annual progress reports.
NDA Collection

A virtual container and organization structure for data and associated documentation from one grant or one large project/consortium. It contains tools for tracking data submission and allows investigators to define a wide array of other elements that provide context for the data, including all general information regarding the data and source project, experimental parameters used to collect any event-based data contained in the Collection, methods, and other supporting documentation. They also allow investigators to link underlying data to an NDA Study, defining populations and subpopulations specific to research aims.
Data Use Limitations

Data Use Limitations (DULs) describe the appropriate secondary use of a dataset and are based on the original informed consent of a research participant. NDA only accepts consent-based data use limitations defined by the NIH Office of Science Policy.
Total Subjects Shared

The total number of unique subjects for whom data have been shared and are available for users with permission to access data.

Contact NDA Help Desk

ID	Name	Created Date	Status	Type
486	Project 3: EEG	06/22/2016	Approved	EEG
487	Project 3: Eye Tracking	06/22/2016	Approved	Eye Tracking
1687	Project 3 P2: intervention	01/19/2021	Approved	EEG
1782	Project 3: talk/listen	06/15/2021	Approved	EEG

helpcenter.collection.experiments-tab

Collection - Experiments

The number of Experiments included is displayed in parentheses next to the tab name. You may download all experiments associated with the Collection via the Download button. You may view individual experiments by clicking the Experiment Name and add them to the Filter Cart via the Add to Cart button.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may create or edit an Experiment.

Please note: The creation of an NDA Experiment does not necessarily mean that data collected, according to the defined Experiment, has been submitted or shared.

Frequently Asked Questions

Can an Experiment be associated with more than one Collection?
Yes -see the “Copy” button in the bottom left when viewing an experiment. There are two actions that can be performed via this button:
1. Copy the experiment with intent for modifications.
2. Associate the experiment to the collection. No modifications can be made to the experiment.

Glossary

Experiment Status

An Experiment must be Approved before data using the associated Experiment_ID may be uploaded.
Experiment ID

The ID number automatically generated by NDA which must be included in the appropriate file when uploading data to link the Experiment Definition to the subject record.

Contact NDA Help Desk

Shared Data:

Title	Type	Number of Subjects
Aberrant Behavior Checklist (ABC) - Community	Clinical Assessments	225
Anxiety Depression and Mood Scale	Clinical Assessments	218
CHARGE Medical History	Clinical Assessments	224
EEG Subject Files	Imaging	323
Edinburgh Handedness Inventory	Clinical Assessments	264
Eye Tracking Subject-Experiment	Imaging	239
Height and Weight	Clinical Assessments	260
Medications	Clinical Assessments	338
Pediatric Anxiety Rating Scale (PARS)	Clinical Assessments	115
Research Subject	Clinical Assessments	346
Social Communication Questionnaire (SCQ) - Lifetime	Clinical Assessments	208
Stanford-Binet Intelligence Scales, Fifth Edition (SB5)	Clinical Assessments	328

helpcenter.collection.shared-data-tab

Collection - Shared Data

This tab provides a quick overview of the Data Structure title, Data Type, and Number of Subjects that are currently Shared for the Collection. The information presented in this tab is automatically generated by NDA and cannot be edited. If no information is visible on this tab, this would indicate the Collection does not have shared data or the data is private.

The shared data is available to other researchers who have permission to access data in the Collection's designated Permission Group(s). Use the Download button to get all shared data from the Collection to the Filter Cart.

Frequently Asked Questions

How will I know if another researcher uses data that I shared through the NIMH Data Archive (NDA)?

To see what data your project have submitted are being used by a study, simply go the Associated Studies tab of your collection. Alternatively, you may review an NDA Study Attribution Report available on the General tab.
Can I get a supplement to share data from a completed research project?

Often it becomes more difficult to organize and format data electronically after the project has been completed and the information needed to create a GUID may not be available; however, you may still contact a program staff member at the appropriate funding institution for more information.
Can I get a supplement to share data from a research project that is still ongoing?

Unlike completed projects where researchers may not have the information needed to create a GUID and/or where the effort needed to organize and format data becomes prohibitive, ongoing projects have more of an opportunity to overcome these challenges. Please contact a program staff member at the appropriate funding institution for more information.

Glossary

Data Structure

A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure
Data Type

A grouping of data by similar characteristics such as Clinical Assessments, Omics, or Neurosignal data.
Shared

The term 'Shared' generally means available to others; however, there are some slightly different meanings based on what is Shared. A Shared NDA Study is viewable and searchable publicly regardless of the user's role or whether the user has an NDA account. A Shared NDA Study does not necessarily mean that data used in the NDA Study have been shared as this is independently determined. Data are shared according the schedule defined in a Collection's Data Expected Tab and/or in accordance with data sharing expectations in the NDA Data Sharing Terms and Conditions. Additionally, Supporting Documentation uploaded to a Collection may be shared independent of whether data are shared.

Contact NDA Help Desk

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Publications

Publications relevant to NDA data are listed below. Most displayed publications have been associated with the grant within Pubmed. Use the "+ New Publication" button to add new publications. Publications relevant/not relevant to data expected are categorized. Relevant publications are then linked to the underlying data by selecting the Create Study link. Study provides the ability to define cohorts, assign subjects, define outcome measures and lists the study type, data analysis and results. Analyzed data and results are expected in this way.

PubMed ID	Study	Title	Journal	Authors	Date	Status
39651602	Create Study	Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome.	Journal of child and adolescent psychopharmacology	McKinney, Walker S; Schmitt, Lauren M; De Stefano, Lisa A; Ethridge, Lauren; Norris, Jordan E; Horn, Paul S; Dauterman, Shelby; Rosselot, Hilary; Pedapati, Ernest V; Reisinger, Debra L; Dominick, Kelli C; Shaffer, Rebecca C; Chin, Danielle; Friedman, Nicole R; Hong, Michael; Sweeney, John A; Erickson, Craig	December 9, 2024	Not Determined
39367109	Create Study	A near normal distribution of IQ in Fragile X Syndrome.	Scientific reports	Schmitt, Lauren M; Nelson, Meredith; Shaffer, Rebecca C; Erickson, Craig A	October 4, 2024	Not Determined
39362936	Create Study	Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome.	Scientific reports	Ethridge, Lauren E; Pedapati, Ernest V; Schmitt, Lauren M; Norris, Jordan E; Auger, Emma; De Stefano, Lisa A; Sweeney, John A; Erickson, Craig A	October 3, 2024	Not Determined
38817342	Create Study	Reliability of resting-state electrophysiology in fragile X syndrome.	Biomarkers in neuropsychiatry	Liu, Rui; Pedapati, Ernest V; Schmitt, Lauren M; Shaffer, Rebecca C; Smith, Elizabeth G; Dominick, Kelli C; DeStefano, Lisa A; Westerkamp, Grace; Horn, Paul; Sweeney, John A; Erickson, Craig A	December 1, 2023	Not Determined
38313274	Create Study	Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome.	Research square	Ethridge, Lauren E; Pedapati, Ernest V; Schmitt, Lauren M; Norris, Jordan E; Auger, Emma; De Stefano, Lisa A; Sweeney, John A; Erickson, Craig A	January 18, 2024	Not Determined
37473758	Create Study	Excitatory neuron-specific suppression of the integrated stress response contributes to autism-related phenotypes in fragile X syndrome.	Neuron	Hooshmandi, Mehdi; Sharma, Vijendra; Thörn Perez, Carolina; Sood, Rapita; Krimbacher, Konstanze; Wong, Calvin; Lister, Kevin C; Ureña Guzmán, Alba; Bartley, Trevor D; Rocha, Cecilia; Maussion, Gilles; Nadler, Emma; Roque, Patricia Margarita; Gantois, Ilse; Popic, Jelena; Lévesque, Maxime; Kaufman, Randal J; Avoli, Massimo; Sanz, Elisenda; Nader, Karim; Hagerman, Randi Jenssen; Durcan, Thomas M; Costa-Mattioli, Mauro; Prager-Khoutorsky, Masha; Lacaille, Jean-Claude; Martinez-Cerdeno, Veronica; Gibson, Jay R; Huber, Kimberly M; Sonenberg, Nahum; Gkogkas, Christos G; Khoutorsky, Arkady	October 4, 2023	Not Determined
37266542	Create Study	Editorial: Recent advances in mechanisms and therapeutics for Fragile X Syndrome and autism.	Frontiers in neuroscience	Molinaro, Gemma; Huber, Kimberly M; McCullagh, Elizabeth A; Thomson, Sophie R	January 1, 2023	Not Determined
37205401	Create Study	A Paradigm Shifting View of Intellectual Disability: A Near Normal Distribution of IQ in Fragile X Syndrome.	Research square	Schmitt, Lauren M; Will, Meredith; Shaffer, Rebecca; Erickson, Craig	May 5, 2023	Not Determined
36882476	Create Study	A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndrome.	Scientific reports	Straub, Devan; Schmitt, Lauren M; Boggs, Anna E; Horn, Paul S; Dominick, Kelli C; Gross, Christina; Erickson, Craig A	March 7, 2023	Not Determined
36688132	Create Study	Parallel learning and cognitive flexibility impairments between Fmr1 knockout mice and individuals with fragile X syndrome.	Frontiers in behavioral neuroscience	Schmitt, Lauren M; Arzuaga, Anna L; Dapore, Ashley; Duncan, Jason; Patel, Maya; Larson, John R; Erickson, Craig A; Sweeney, John A; Ragozzino, Michael E	January 1, 2022	Not Determined
36494861	Create Study	Altered frontal connectivity as a mechanism for executive function deficits in fragile X syndrome.	Molecular autism	Schmitt, Lauren M; Li, Joy; Liu, Rui; Horn, Paul S; Sweeney, John A; Erickson, Craig A; Pedapati, Ernest V	December 9, 2022	Not Determined
36411085	Create Study	Hemispheric Utilization of Alpha Oscillatory Dynamics as a Unique Biomarker of Neural Compensation in Females with Fragile X Syndrome.	ACS chemical neuroscience	Norris, Jordan E; DeStefano, Lisa A; Schmitt, Lauren M; Pedapati, Ernest V; Erickson, Craig A; Sweeney, John A; Ethridge, Lauren E	December 7, 2022	Not Determined
36167501	Create Study	Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome.	Journal of neurodevelopmental disorders	Jonak, Carrie R; Pedapati, Ernest V; Schmitt, Lauren M; Assad, Samantha A; Sandhu, Manbir S; DeStefano, Lisa; Ethridge, Lauren; Razak, Khaleel A; Sweeney, John A; Binder, Devin K; Erickson, Craig A	September 27, 2022	Not Determined
35588990	Create Study	A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons.	Neurobiology of disease	Holley, Andrew J; Shedd, Aleya; Boggs, Anna; Lovelace, Jonathan; Erickson, Craig; Gross, Christina; Jankovic, Miranda; Razak, Khaleel; Huber, Kimberly; Gibson, Jay R	August 1, 2022	Not Determined
35379866	Create Study	Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots.	Scientific reports	Boggs, Anna E; Schmitt, Lauren M; McLane, Richard D; Adayev, Tatyana; LaFauci, Giuseppe; Horn, Paul S; Dominick, Kelli C; Gross, Christina; Erickson, Craig A	April 4, 2022	Not Determined
34871737	Create Study	Functional consequences of postnatal interventions in a mouse model of Fragile X syndrome.	Neurobiology of disease	Rais, Maham; Lovelace, Jonathan W; Shuai, Xinghao S; Woodard, Walker; Bishay, Steven; Estrada, Leo; Sharma, Ashwin R; Nguy, Austin; Kulinich, Anna; Pirbhoy, Patricia S; Palacios, Arnold R; Nelson, David L; Razak, Khaleel A; Ethell, Iryna M	January 1, 2022	Not Relevant
34645383	Create Study	Increased 2-arachidonoyl-sn-glycerol levels normalize cortical responses to sound and improve behaviors in Fmr1 KO mice.	Journal of neurodevelopmental disorders	Pirbhoy, Patricia S; Jonak, Carrie R; Syed, Rashid; Argueta, Donovan A; Perez, Pedro A; Wiley, Mark B; Hessamian, Keon; Lovelace, Jonathan W; Razak, Khaleel A; DiPatrizio, Nicholas V; Ethell, Iryna M; Binder, Devin K	October 13, 2021	Not Relevant
34617509	Create Study	Experience-dependent weakening of callosal synaptic connections in the absence of postsynaptic FMRP.	eLife	Zhang, Zhe; Gibson, Jay R; Huber, Kimberly M	October 7, 2021	Not Relevant
34430906	Create Study	BIOMARKERS AND NEUROBEHAVIORAL DIAGNOSIS.	Biomarkers in neuropsychiatry	Ewen, Joshua B; Potter, William Z; Sweeney, John A	June 1, 2021	Not Determined
32924010	Create Study	A neurophysiological model of speech production deficits in fragile X syndrome.	Brain communications	Schmitt, Lauren M; Wang, Jun; Pedapati, Ernest V; Thurman, Angela John; Abbeduto, Leonard; Erickson, Craig A; Sweeney, John A	January 1, 2020	Relevant
32434848	Create Study	Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome.	Science translational medicine	McCamphill, Patrick K; Stoppel, Laura J; Senter, Rebecca K; Lewis, Michael C; Heynen, Arnold J; Stoppel, David C; Sridhar, Vinay; Collins, Katie A; Shi, Xi; Pan, Jen Q; Madison, Jon; Cottrell, Jeffrey R; Huber, Kimberly M; Scolnick, Edward M; Holson, Edward B; Wagner, Florence F; Bear, Mark F	May 20, 2020	Not Relevant
32374912	Create Study	Acute pharmacological inhibition of matrix metalloproteinase-9 activity during development restores perineuronal net formation and normalizes auditory processing in Fmr1 KO mice.	Journal of neurochemistry	Pirbhoy, Patricia S; Rais, Maham; Lovelace, Jonathan W; Woodard, Walker; Razak, Khaleel A; Binder, Devin K; Ethell, Iryna M	December 1, 2020	Not Relevant
32359368	Create Study	Developmental studies in fragile X syndrome.	Journal of neurodevelopmental disorders	Razak KA, Dominick KC, Erickson CA	May 2020	Not Relevant
32319849	Create Study	Abnormal development of auditory responses in the inferior colliculus of a mouse model of Fragile X Syndrome.	Journal of neurophysiology	Nguyen, Anna O; Binder, Devin K; Ethell, Iryna M; Razak, Khaleel A	June 2020	Not Relevant
32234480	Create Study	FMRP Control of Ribosome Translocation Promotes Chromatin Modifications and Alternative Splicing of Neuronal Genes Linked to Autism.	Cell reports	Shah, Sneha; Molinaro, Gemma; Liu, Botao; Wang, Ruijia; Huber, Kimberly M; Richter, Joel D	March 2020	Not Relevant
32039504	Create Study	Mechanisms underlying auditory processing deficits in Fragile X syndrome.	FASEB journal : official publication of the Federation of American Societies for Experimental Biology	McCullagh, Elizabeth A; Rotschafer, Sarah E; Auerbach, Benjamin D; Klug, Achim; Kaczmarek, Leonard K; Cramer, Karina S; Kulesza Jr, Randy J; Razak, Khaleel A; Lovelace, Jonathan W; Lu, Yong; Koch, Ursula; Wang, Yuan	March 2020	Not Relevant
32036032	Create Study	Multielectrode array analysis of EEG biomarkers in a mouse model of Fragile X Syndrome.	Neurobiology of disease	Jonak, Carrie R; Lovelace, Jonathan W; Ethell, Iryna M; Razak, Khaleel A; Binder, Devin K	May 1, 2020	Not Determined
31991905	Create Study	The Relationship between Expressive Language Sampling and Clinical Measures in Fragile X Syndrome and Typical Development.	Brain sciences	Shaffer, Rebecca C; Schmitt, Lauren; John Thurman, Angela; Abbeduto, Leonard; Hong, Michael; Pedapati, Ernest; Dominick, Kelli; Sweeney, John; Erickson, Craig	January 2020	Not Relevant
31666356	Create Study	Audiogenic Seizures in the Fmr1 Knock-Out Mouse Are Induced by Fmr1 Deletion in Subcortical, VGlut2-Expressing Excitatory Neurons and Require Deletion in the Inferior Colliculus.	The Journal of neuroscience : the official journal of the Society for Neuroscience	Gonzalez, Darya; Tomasek, Madison; Hays, Seth; Sridhar, Vinay; Ammanuel, Simon; Chang, Chia-Wei; Pawlowski, Karen; Huber, Kimberly M; Gibson, Jay R	December 4, 2019	Not Relevant
31649514	Study (1227)	Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance.	Frontiers in integrative neuroscience	Ethridge LE, De Stefano LA, Schmitt LM, Woodruff NE, Brown KL, Tran M, Wang J, Pedapati EV, Erickson CA, Sweeney JA	2019	Relevant
31364704	Create Study	Deletion of Fmr1 from Forebrain Excitatory Neurons Triggers Abnormal Cellular, EEG, and Behavioral Phenotypes in the Auditory Cortex of a Mouse Model of Fragile X Syndrome.	Cerebral cortex (New York, N.Y. : 1991)	Lovelace, Jonathan W; Rais, Maham; Palacios, Arnold R; Shuai, Xinghao S; Bishay, Steven; Popa, Otilia; Pirbhoy, Patricia S; Binder, Devin K; Nelson, David L; Ethell, Iryna M; Razak, Khaleel A	March 2020	Not Relevant
31326533	Create Study	Reduced perineuronal net expression in Fmr1 KO mice auditory cortex and amygdala is linked to impaired fear-associated memory.	Neurobiology of learning and memory	Reinhard, Sarah M; Rais, Maham; Afroz, Sonia; Hanania, Yasmien; Pendi, Kasim; Espinoza, Katherine; Rosenthal, Robert; Binder, Devin K; Ethell, Iryna M; Razak, Khaleel A	October 2019	Not Relevant
31271818	Create Study	Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.	Behavioural brain research	Toledo, Maximiliano A; Wen, Teresa H; Binder, Devin K; Ethell, Iryna M; Razak, Khaleel A	October 2019	Not Relevant
31128097	Create Study	Genetic reduction of MMP-9 in the Fmr1 KO mouse partially rescues prepulse inhibition of acoustic startle response.	Brain research	Kokash, Jamiela; Alderson, Erin M; Reinhard, Sarah M; Crawford, Cynthia A; Binder, Devin K; Ethell, Iryna M; Razak, Khaleel A	September 2019	Not Relevant
30665413	Create Study	Differentiating social preference and social anxiety phenotypes in fragile X syndrome using an eye gaze analysis: a pilot study.	Journal of neurodevelopmental disorders	Hong, Michael P; Eckert, Eleanor M; Pedapati, Ernest V; Shaffer, Rebecca C; Dominick, Kelli C; Wink, Logan K; Sweeney, John A; Erickson, Craig A	January 2019	Not Relevant
30639292	Create Study	Local cortical circuit correlates of altered EEG in the mouse model of Fragile X syndrome.	Neurobiology of disease	Goswami, Sonal; Cavalier, Sheridan; Sridhar, Vinay; Huber, Kimberly M; Gibson, Jay R	April 2019	Not Relevant
30528856	Create Study	Developmental Changes in EEG Phenotypes in a Mouse Model of Fragile X Syndrome.	Neuroscience	Wen, Teresa H; Lovelace, Jonathan W; Ethell, Iryna M; Binder, Devin K; Razak, Khaleel A	February 2019	Not Relevant
30416434	Create Study	Reusable Multielectrode Array Technique for Electroencephalography in Awake Freely Moving Mice.	Frontiers in integrative neuroscience	Jonak, Carrie R; Lovelace, Jonathan W; Ethell, Iryna M; Razak, Khaleel A; Binder, Devin K	January 2018	Not Relevant
30250263	Create Study	Impaired perceptual learning in a mouse model of Fragile X syndrome is mediated by parvalbumin neuron dysfunction and is reversible.	Nature neuroscience	Goel, Anubhuti; Cantu, Daniel A; Guilfoyle, Janna; Chaudhari, Gunvant R; Newadkar, Aditi; Todisco, Barbara; de Alba, Diego; Kourdougli, Nazim; Schmitt, Lauren M; Pedapati, Ernest; Erickson, Craig A; Portera-Cailliau, Carlos	October 2018	Not Relevant
30231625	Create Study	Sensory Processing Phenotypes in Fragile X Syndrome.	ASN neuro	Rais, Maham; Binder, Devin K; Razak, Khaleel A; Ethell, Iryna M	January 2018	Not Relevant
30123106	Create Study	The Perineuronal ''Safety'' Net? Perineuronal Net Abnormalities in Neurological Disorders.	Frontiers in molecular neuroscience	Wen, Teresa H; Binder, Devin K; Ethell, Iryna M; Razak, Khaleel A	January 2018	Not Relevant
29605426	Create Study	Translation-relevant EEG phenotypes in a mouse model of Fragile X Syndrome.	Neurobiology of disease	Lovelace, Jonathan W; Ethell, Iryna M; Binder, Devin K; Razak, Khaleel A	July 2018	Not Relevant
29040407	Create Study	Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice.	Cerebral cortex (New York, N.Y. : 1991)	Wen, Teresa H; Afroz, Sonia; Reinhard, Sarah M; Palacios, Arnold R; Tapia, Kendal; Binder, Devin K; Razak, Khaleel A; Ethell, Iryna M	November 2018	Not Relevant
29027913	Create Study	Neural Hyperexcitability in Autism Spectrum Disorders.	Brain sciences	Takarae, Yukari; Sweeney, John	October 2017	Not Relevant
28616096	Create Study	Fragile X targeted pharmacotherapy: lessons learned and future directions.	Journal of neurodevelopmental disorders	Erickson CA, Davenport MH, Schaefer TL, Wink LK, Pedapati EV, Sweeney JA, Fitzpatrick SE, Brown WT, Budimirovic D, Hagerman RJ, Hessl D, Kaufmann WE, Berry-Kravis E	2017	Not Relevant
28616095	Create Study	Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.	Journal of neurodevelopmental disorders	Schaefer TL, Davenport MH, Grainger LM, Robinson CK, Earnheart AT, Stegman MS, Lang AL, Ashworth AA, Molinaro G, Huber KM, Erickson CA	2017	Not Relevant
28596820	Create Study	Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.	Molecular autism	Ethridge LE, White SP, Mosconi MW, Wang J, Pedapati EV, Erickson CA, Byerly MJ, Sweeney JA	January 2017	Not Determined
28540866	Create Study	Electrophysiological signatures of atypical intrinsic brain connectivity networks in autism.	Journal of neural engineering	Shou G, Mosconi MW, Wang J, Ethridge LE, Sweeney JA, Ding L	August 2017	Not Relevant
28316753	Create Study	A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome.	Journal of neurodevelopmental disorders	Wang, Jun; Ethridge, Lauren E; Mosconi, Matthew W; White, Stormi P; Binder, Devin K; Pedapati, Ernest V; Erickson, Craig A; Byerly, Matthew J; Sweeney, John A	January 2017	Not Determined
28018172	Create Study	APP Causes Hyperexcitability in Fragile X Mice.	Frontiers in molecular neuroscience	Westmark, Cara J; Chuang, Shih-Chieh; Hays, Seth A; Filon, Mikolaj J; Ray, Brian C; Westmark, Pamela R; Gibson, Jay R; Huber, Kimberly M; Wong, Robert K S	January 2016	Not Relevant
27504143	Create Study	Neurophysiological hyperresponsivity to sensory input in autism spectrum disorders.	Journal of neurodevelopmental disorders	Takarae, Yukari; Sablich, Savanna R; White, Stormi P; Sweeney, John A	January 2016	Not Relevant
27235081	Create Study	Sensory processing in autism spectrum disorders and Fragile X syndrome-From the clinic to animal models.	Neuroscience and biobehavioral reviews	Sinclair, D; Oranje, B; Razak, K A; Siegel, S J; Schmid, S	May 2017	Not Relevant
27093069	Create Study	Reduced habituation of auditory evoked potentials indicate cortical hyper-excitability in Fragile X Syndrome.	Translational psychiatry	Ethridge LE, White SP, Mosconi MW, Wang J, Byerly MJ, Sweeney JA	2016	Not Determined
26888925	Create Study	Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.	The Journal of neuroscience : the official journal of the Society for Neuroscience	Guo W, Molinaro G, Collins KA, Hays SA, Paylor R, Worley PF, Szumlinski KK, Huber KM	February 2016	Not Relevant
26850918	Create Study	Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.	Neurobiology of disease	Lovelace JW, Wen TH, Reinhard S, Hsu MS, Sidhu H, Ethell IM, Binder DK, Razak KA	May 2016	Not Relevant
26670047	Create Study	Elevated CaMKIIα and Hyperphosphorylation of Homer Mediate Circuit Dysfunction in a Fragile X Syndrome Mouse Model.	Cell reports	Guo W, Ceolin L, Collins KA, Perroy J, Huber KM	December 15, 2015	Not Relevant
26663516	Create Study	Atypical age-dependent effects of autism on white matter microstructure in children of 2-7 years.	Human brain mapping	Ouyang, Minhui; Cheng, Hua; Mishra, Virendra; Gong, Gaolang; Mosconi, Matthew W; Sweeney, John; Peng, Yun; Huang, Hao	February 2016	Not Relevant
26388713	Create Study	The role of cerebellar circuitry alterations in the pathophysiology of autism spectrum disorders.	Frontiers in neuroscience	Mosconi, Matthew W; Wang, Zheng; Schmitt, Lauren M; Tsai, Peter; Sweeney, John A	2015	Not Relevant
26335740	Create Study	Sensorimotor dysfunctions as primary features of autism spectrum disorders.	Science China. Life sciences	Mosconi, Matthew W; Sweeney, John A	October 2015	Not Relevant
26262902	Create Study	Pharmacogenetic Study of Serotonin Transporter and 5HT2A Genotypes in Autism.	Journal of child and adolescent psychopharmacology	Najjar, Fedra; Owley, Thomas; Mosconi, Matthew W; Jacob, Suma; Hur, Kwan; Guter, Stephen J; Sweeney, John A; Gibbons, Robert D; Cook, Edwin H; Bishop, Jeffrey R	August 2015	Not Relevant
25653359	Create Study	Feedforward and feedback motor control abnormalities implicate cerebellar dysfunctions in autism spectrum disorder.	The Journal of neuroscience : the official journal of the Society for Neuroscience	Mosconi, Matthew W; Mohanty, Suman; Greene, Rachel K; Cook, Edwin H; Vaillancourt, David E; Sweeney, John A	February 4, 2015	Not Relevant
25234483	Create Study	Cognitive set shifting deficits and their relationship to repetitive behaviors in autism spectrum disorder.	Journal of autism and developmental disorders	Miller, Haylie L; Ragozzino, Michael E; Cook, Edwin H; Sweeney, John A; Mosconi, Matthew W	March 2015	Not Relevant
24894823	Create Study	Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice.	Autism research : official journal of the International Society for Autism Research	Amodeo DA, Jones JH, Sweeney JA, Ragozzino ME	October 2014	Not Relevant

helpcenter.collection.publications-tab

Collection - Publications

The number of Publications is displayed in parentheses next to the tab name. Clicking on any of the Publication Titles will open the Publication in a new internet browsing tab.

Collection Owners, Program Officers, and users with Submission or Administrative Privileges for the Collection may mark a publication as either Relevant or Not Relevant in the Status column.

Frequently Asked Questions

How can I determine if a publication is relevant?

Publications are considered relevant to a collection when the data shared is directly related to the project or collection.
Where does the NDA get the publications?

PubMed, an online library containing journals, articles, and medical research. Sponsored by NiH and National Library of Medicine (NLM).

Glossary

Create Study

A link to the Create an NDA Study page that can be clicked to start creating an NDA Study with information such as the title, journal and authors automatically populated.
Not Determined Publication

Indicates that the publication has not yet been reviewed and/or marked as Relevant or Not Relevant so it has not been determined whether an NDA Study is expected.
Not Relevant Publication

A publication that is not based on data related to the aims of the grant/project associated with the Collection or not based on any data such as a review article and, therefore, an NDA Study is not expected to be created.
PubMed

PubMed provides citation information for biomedical and life sciences publications and is managed by the U.S. National Institutes of Health's National Library of Medicine.
PubMed ID

The PUBMed ID is the unique ID number for the publication as recorded in the PubMed database.
Relevant Publication

A publication that is based on data related to the aims of the grant/project associated with the Collection and, therefore, an NDA Study is expected to be created.

Contact NDA Help Desk

Data Expected List: Mandatory Data Structures

These data structures are mandatory for your NDA Collection. Please update the Targeted Enrollment number to accurately represent the number of subjects you expect to submit for the entire study.

For NIMH HIV-related research that involves human research participants: Select the dictionary or dictionaries most appropriate for your research. If your research does not require all three data dictionaries, just ignore the ones you do not need. There is no need to delete extra data dictionaries from your NDA Collection. You can adjust the Targeted Enrollment column in the Data Expected tab to “0” for those unnecessary data dictionaries. At least one of the three data dictionaries must have a non-zero value.

Data Expected	Targeted Enrollment	Initial Submission	Subjects Submitted	Initial Share	Subjects Shared	Status
Research Subject and Pedigree	250	07/15/2016	346	11/15/2016	346	Approved

To create your project's Data Expected list, use the "+New Data Expected" to add or request existing structures and to request new Data Structures that are not in the NDA Data Dictionary.

If the Structure you need already exists, locate it and specify your dates and enrollment when adding it to your Data Expected list. If you require changes to the Structure you need, select the indicator stating "No, it requires changes to meet research needs," and upload a file containing your requested changes.

If the structure you need is not yet defined in the Data Dictionary, you can select "Upload Definition" and attach the necessary materials to request its creation.

When selecting the expected dates for your data, make sure to follow the standard Data Sharing Regimen and choose dates within the date ranges that correspond to your project start and end dates.

Please visit the Completing Your Data Expected Tutorial for more information.

Data Expected List: Data Structures per Research Aims

These data structures are specific to your research aims and should list all data structures in which data will be collected and submitted for this NDA Collection. Please update the Targeted Enrollment number to accurately represent the number of subjects you expect to submit for the entire study.

Data Expected	Targeted Enrollment	Initial Submission	Subjects Submitted	Initial Share	Subjects Shared	Status
ABC Community	150	07/15/2016	227	05/31/2020	225	Approved
Medical History	250	07/15/2016	224	11/15/2016	224	Approved
Eye Tracking	250	07/15/2016	239	05/31/2020	239	Approved
Social Communication Questionnaire (SCQ)	250	01/15/2017	208	05/31/2020	208	Approved
Grooved Pegboard Test	36	05/31/2020	29	05/31/2021	0	Approved
Pediatric Anxiety Rating Scale (PARS)	150	07/15/2016	115	05/31/2020	115	Approved
Medications	250	07/15/2016	338	05/31/2020	338	Approved
Stanford Binet	250	07/15/2016	330	05/31/2020	328	Approved
Physical Exam	250	07/15/2016	268	05/31/2020	268	Approved
EEG	250	07/15/2016	324	05/31/2020	323	Approved
Anxiety Depression and Mood Scale	150	07/15/2016	219	05/31/2020	218	Approved
Repeatable Battery for the Assessment of Neuropsychological Status	36	05/30/2020	0	05/31/2021	0	Approved
KiTAP	36	05/30/2019	28	05/30/2020	0	Approved

Structure not yet defined

No Status history for this Data Expected has been recorded yet

helpcenter.collection.data-expected-tab

Collection - Data Expected

The Data Expected tab displays the list of all data that NDA expects to receive in association with the Collection as defined by the contributing researcher, as well as the dates for the expected initial upload of the data, and when it is first expected to be shared, or with the research community. Above the primary table of Data Expected, any publications determined to be relevant to the data within the Collection are also displayed - members of the contributing research group can use these to define NDA Studies, connecting those papers to underlying data in NDA.

The tab is used both as a reference for those accessing shared data, providing information on what is expected and when it will be shared, and as the primary tracking mechanism for contributing projects. It is used by both contributing primary researchers, secondary researchers, and NIH Program and Grants Management staff.

Researchers who are starting their project need to update their Data Expected list to include all the Data Structures they are collecting under their grant and set their initial submission and sharing schedule according to the NDA Data Sharing Regimen.

To add existing Data Structures from the Data Dictionary, to request new Data Structure that are not in the Dictionary, or to request changes to existing Data Structures, click "+New Data Expected".

For step-by-step instructions on how to add existing Data Structures, request changes to an existing Structure, or request a new Data Structure, please visit the Completing Your Data Expected Tutorial.

If you are a contributing researcher creating this list for the first time, or making changes to the list as your project progress, please note the following:

Although items you add to the list and changes you make are displayed, they are not committed to the system until you Save the entire page using the "Save" button at the bottom of your screen. Please Save after every change to ensure none of your work is lost.
If you attempt to add a new structure, the title you provide must be unique - if another structure exists with the same name your change will fail.
Adding a new structure to this list is the only way to request the creation of a new Data Dictionary definition.

Frequently Asked Questions

What is an NDA Data Structure?

An NDA Data Structure is comprised of multiple Data Elements to make up an electronic definition of an assessment, measure, questionnaire, etc will have a corresponding Data Structure.
What is the NDA Data Dictionary?

The NDA Data Dictionary is comprised of electronic definitions known as Data Structures.

Glossary

Analyzed Data

Data specific to the primary aims of the research being conducted (e.g. outcome measures, other dependent variables, observations, laboratory results, analyzed images, volumetric data, etc.) including processed images.
Data Item

Items listed on the Data Expected list in the Collection which may be an individual and discrete Data Structure, Data Structure Category, or Data Structure Group.
Data Structure

A defined organization and group of Data Elements to represent an electronic definition of a measure, assessment, questionnaire, or collection of data points. Data structures that have been defined in the NDA Data Dictionary are available at https://nda.nih.gov/general-query.html?q=query=data-structure
Data Structure Category

An NDA term describing the affiliation of a Data Structure to a Category, which may be disease/disorder or diagnosis related (Depression, ADHD, Psychosis), specific to data type (MRI, eye tracking, omics), or type of data (physical exam, IQ).
Data Structure Group

A Data Item listed on the Data Expected tab of a Collection that indicates a group of Data Structures (e.g., ADOS or SCID) for which data may be submitted instead of a specific Data Structure identified by version, module, edition, etc. For example, the ADOS Data Structure Category includes every ADOS Data Structure such as ADOS Module 1, ADOS Module 2, ADOS Module 1 - 2nd Edition, etc. The SCID Data Structure Group includes every SCID Data Structure such as SCID Mania, SCID V Mania, SCID PTSD, SCID-V Diagnosis, and more.
Evaluated Data

A new Data Structure category, Evaluated Data is analyzed data resulting from the use of computational pipelines in the Cloud and can be uploaded directly back to a miNDAR database. Evaluated Data is expected to be listed as a Data Item in the Collection's Data Expected Tab.
Imaging Data

Imaging+ is an NDA term which encompasses all imaging related data including, but not limited to, images (DTI, MRI, PET, Structural, Spectroscopy, etc.) as well as neurosignal data (EEG, fMRI, MEG, EGG, eye tracking, etc.) and Evaluated Data.
Initial Share Date

Initial Submission and Initial Share dates should be populated according to the NDA Data Sharing Terms and Conditions. Any modifications to these will go through the approval processes outlined above. Data will be shared with authorized users upon publication (via an NDA Study) or 1-2 years after the grant end date specified on the first Notice of Award, as defined in the applicable Data Sharing Terms and Conditions.
Initial Submission Date

Initial Submission and Initial Share dates should be populated according to these NDA Data Sharing Terms and Conditions. Any modifications to these will go through the approval processes outlined above. Data for all subjects is not expected on the Initial Submission Date and modifications may be made as necessary based on the project's conduct.
Research Subject and Pedigree

An NDA created Data Structure used to convey basic information about the subject such as demographics, pedigree (links family GUIDs), diagnosis/phenotype, and sample location that are critical to allow for easier querying of shared data.
Submission Cycle

The NDA has two Submission Cycles per year - January 15 and July 15.
Submission Exemption

An interface to notify NDA that data may not be submitted during the upcoming/current submission cycle.

Contact NDA Help Desk

Collection Owners and those with Collection Administrator permission, may edit a collection. The following is currently available for Edit on this page:

Associated Studies

Studies that have been defined using data from a Collection are important criteria to determine the value of data shared. The number of subjects column displays the counts from this Collection that are included in a Study, out of the total number of subjects in that study. The Data Use column represents whether or not the study is a primary analysis of the data or a secondary analysis. State indicates whether the study is private or shared with the research community.

Study NameFilter by Study Name	AbstractFilter by Abstract	Collection/Study SubjectsFilter by Collection/Study Subjects	Data UsageFilter by Data Usage	StateFilter by State
Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance.	= 40, Mean age = 27.7, std = 12.1; 17 females) completed auditory chirp and auditory habituation tasks while undergoing dense array electroencephalography (EEG). Amplitude, latency, and percent change (habituation) in N1 and P2 event-related potential (ERP) components were characterized for the habituation task; time-frequency calculations using Morlet wavelets characterized phase-locking and single trial power for the habituation and chirp tasks. FXS patients showed increased amplitude but some evidence for reduced habituation of the N1 ERP, and reduced phase-locking in the low and high gamma frequency range and increased low gamma power to the chirp stimulus. FXS showed increased theta power in both tasks. While the habituation finding was weaker than previously found, the remaining findings replicate our previous work in a new sample of patients with FXS. Females showed less deficit in the chirp task but not the habituation task. Abnormal increases in gamma power were related to more severe behavioral and psychiatric features as well as reductions in neurocognitive abilities. Replicating electrophysiological deficits in a new group of patients using different EEG equipment at a new data collection site with differing levels of environmental noise that were robust to data processing techniques utilizing multiple researchers, indicates a potential for scalability to multi-site clinical trials. Given the robust replicability, relevance to clinical measures, and preclinical evidence for sensitivity of these EEG measures to pharmacological intervention, the observed abnormalities may provide novel translational markers of target engagement and potentially outcome measures in large-scale studies evaluating new treatments targeting neural hyperexcitability in FXS.	77/77	Primary Analysis	Shared

* Data not on individual level

helpcenter.collection.associated-studies-tab

Collection - Associated Studies

Clicking on the Study Title will open the study details in a new internet browser tab. The Abstract is available for viewing, providing the background explanation of the study, as provided by the Collection Owner.

Primary v. Secondary Analysis: The Data Usage column will have one of these two choices. An associated study that is listed as being used for Primary Analysis indicates at least some and potentially all of the data used was originally collected by the creator of the NDA Study. Secondary Analysis indicates the Study owner was not involved in the collection of data, and may be used as supporting data.

Private v. Shared State: Studies that remain private indicate the associated study is only available to users who are able to access the collection. A shared study is accessible to the general public.

Frequently Asked Questions

How do I associate a study to my collection?

Studies are associated to the Collection automatically when the data is defined in the Study.

Glossary

Associated Studies Tab

A tab in a Collection that lists the NDA Studies that have been created using data from that Collection including both Primary and Secondary Analysis NDA Studies.

Contact NDA Help Desk

Edit

Choose File:	Select File
File Type:
Description:

Exemption Type*
From Date*
To Date*
Reason*	Characters Remaining:

Disclaimer

Filter Cart

Frequently Asked Questions

Glossary